Astellas announces reimbursement for Xospata (gilteritinib) in most provinces for patients with relapsed or refractory acute myeloid leukaemia with a FLT3 mutation

21 April 2022 - Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed ...

Read more →

Valeo Pharma obtains public reimbursement for Enerzair Breezhaler and Atectura Breezhaler in Ontario, Manitoba and New Brunswick

24 February 2022 - Private insurance coverage across Canada exceeds 90%. ...

Read more →

Manitoba is Canada’s first province to nab home grown vaccine

12 February 2021 - Manitoba to buy 2 million doses of yet to be approved vaccine. ...

Read more →

AbbVie announces new formulary listings for Skyrizi in the treatment of moderate to severe plaque psoriasis

12 March 2020 - Non-Insured Health Benefits program lists Skyrizi on its formulary effective 21 February 2020. ...

Read more →

NDP promises to restore special drugs program

4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...

Read more →

Manitoba Liberals promise to opt into national Pharmacare program

4 September 2019 - Liberals say Pallister won't sign onto such a program but Tories say they've been trying to get ...

Read more →